Fundamental Analysis of HUTCHMED (China) Ltd. - Growth / Value Index
HCM - Valuation Highlights
Valuation Analysis
Price to Earning Ratio is 182.57 and EV to EBITDA is 129.91 suggesting that it is very expensive
Price to Book Ratio of 21.79 suggesting that it is very expensive
Book Value in last 3 years is trending down
Valuation Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Price to Earning | 172.08 | 170.85 | 1903.95 % | |
| Price to Book | 20.54 | 23.16 | 331.64 % | 23.16 |
| Price to Sales | 20.69 | 20.55 | 156.37 % | |
| Enterprise Value to EBITDA Multiple | 122.01 | 155.06 | 1710.71 % |
HCM - Profitability Highlights
Profitability Analysis
Piotroski F Score - Excellent Value of 8.0
Net profit has jumped from negative to positive
Company Earning excess return
Good Return On Capital Employed of 12.48
Good Return on Equity of 17.66% is achieved by the company
Good Net Margin of 12.03% is achieved by the company
Tsr Profitability Index - Poor Score of 22.50
Very Low Dividend Yield of 0 %
Negative Net Margin MRQ
Profitability Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Return On Equity | 17.66 | 13.80 | 123.34 % | -4.64 |
| Return On Asset | 8.15 | 7.87 | 122.47 % | -2.65 |
| Net Profit Margin | 12.03 | 12.03 | 114.21 % | -22.21 |
| Operating Profit Margin | 2.19 | 2.19 | 102.29 % | -30.57 |
| EBITDA Margin | 3.17 | 13.10 | 115.87 % | -29.13 |
Highlights
| Market Cap | 3443.60 M |
| Enterprise Value | 3243.29 M |
| Price/Book TTM | 20.54 |
| Outstanding Share | 170728 K |
| Float/ Outstanding Share | 587.15% |
| Dividend Yield | 0 % |
Share Holding
Guru Numbers
| Price/Graham No | 13.31 |
| Peter Lynch Ratio | 0 |
| Piotroski F Score | 8.00 |
| Altman Z Score | 4.47 |
| Sloan Ratio | -0.093 |
| Peter Lynch Fair Value | 2.93 |
HCM - Growth Highlights
Growth Analysis
STRONG JUMP IN NET SALE : YoY growth
Tremendous increasing trend in total sale last 3 year
Quarterly sales in last 5 Quarter is trending down
Growth Key Fields
| Field | TTM | YoY Growth | QoQ Growth |
|---|---|---|---|
| Revenue | 837999 K | 96.52 % | 0 % |
| Gross Profit | 151551 K | 293.35 % | 0 % |
| EBITDA | 26582.00 K | 131.20 % | 0 % |
| Net Profit | 100780 K | 127.93 % | 0 % |
| EPS | 0.117 | 105.54 % | NA |
HCM - Stability Highlights
Stability Analysis
Tsr Stability Index - Excellent Score of 82.81
Altman Z Score of 4.70 suggests good Stability
Paid More Than 50% of Debt, Heading towards debt free
Stability Key Ratios
| Ratio | Latest FY | Yoy Change | MRQ |
|---|---|---|---|
| Debt to Equity Ratio | 0.114 | -75.39 % | 0.114 |
| Cash Ratio | 2.20 | 23.35 % | |
| Quick Ratio | 2.60 | 17.34 % | 2.60 |
| Shareholders Equity | 57.08 | -3.72 % | |
| Debt to EBITDA | 0.759 | 194.41 % |
Historical Valuation Ratios of HUTCHMED (China) Ltd.
Historical Valuation Ratios
Loading ...
Historical Profitability Ratios of HUTCHMED (China) Ltd.
Historical Profitability Ratios
Loading ...
Historical Efficiency Ratios of HUTCHMED (China) Ltd.
Historical Efficiency Ratios
Loading ...
Historical Solvency Ratios of HUTCHMED (China) Ltd.
Historical Solvency Ratios
Loading ...
Note : All Data Generated at the End of Trading Hours (EOD Data)